Custom-made Ceramic Barrier vs Titanium Mesh
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03734094 |
|
Recruitment Status :
Completed
First Posted : November 7, 2018
Last Update Posted : December 21, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Bone Loss | Device: Ceramic barrier Device: Titanium Mesh | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 14 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Treatment |
| Official Title: | Comparative Study Between Custom-made Ceramic Barrier and Titanium Mesh for Augmentation of Atrophic Posterior Mandible |
| Actual Study Start Date : | July 1, 2018 |
| Actual Primary Completion Date : | July 1, 2018 |
| Actual Study Completion Date : | July 1, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Ceramic Barrier
The use of a ceramic barrier to induce bone formation during GBR
|
Device: Titanium Mesh
The use of a titanium mesh to induce bone formation during GBR |
|
Active Comparator: Titanium mesh
The use of a titanium mesh to induce bone formation during GBR
|
Device: Ceramic barrier
The use of a ceramic barrier to induce bone formation during GBR |
- Bone height [ Time Frame: 6 months ]CBCT & Three dimensional planning software to measure the height of bone gained in millimeters.
- Bone width [ Time Frame: 6 months ]CBCT & Three dimensional planning software to measure the width of bone gained in millimeters.
- Histomorphometric - bone area percent [ Time Frame: 6 months ]Histomorphometric analysis of bone area percent
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients with atrophic posterior mandible
- Both sexes
- No intraoral soft and hard tissue pathology
- No systemic condition that contraindicate implant placement
Exclusion Criteria:
- Untreated gingivitis
- Periodontitis
- Insufficient oral hygiene
- Previous radiation therapy
- Head and neck neoplasia
- Systemic disorders
- Heavy smokers
- Bone pathology
- Psychiatric problems
- Emotional instability
- Unrealistic aesthetic demands
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03734094
| Egypt | |
| Cairo University | |
| Cairo, Egypt, 12611 | |
| Responsible Party: | Mohamed El Saharty, Principal Investigator, Cairo University |
| ClinicalTrials.gov Identifier: | NCT03734094 |
| Other Study ID Numbers: |
737 |
| First Posted: | November 7, 2018 Key Record Dates |
| Last Update Posted: | December 21, 2018 |
| Last Verified: | December 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

